Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022104 (
irritable bowel syndrome
)
8,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
On the basis of the observations that chronic nonspecific diarrhea is a precursor of
irritable colon
syndrome and that chronic nonspecific diarrhea is associated with attention deficit disorder in childhood, the authors conducted a psychiatric diagnostic evaluation of 22 adults with
irritable colon
syndrome. Six (27%) of the patients received a diagnosis of attention deficit disorder, residual type, six (27%) were diagnosed as having
dysthymic disorder
, and five (23%) had had episodes of unipolar depression. The relationship between the presence of these disorders and greater severity of
irritable colon
syndrome was statistically significant.
...
PMID:Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. 665 Jun 87
Chronic pelvic pain and
irritable bowel syndrome
are common disorders, yet very little is known about their comorbidity. As part of an epidemiological study of patients with
irritable bowel syndrome
or irritable bowel disease we inquired about a history of chronic pelvic pain and related gynecological problems, and hypothesized that distress associated with either of these conditions was additive in women with both syndromes. A medically trained interviewer evaluated a sequential sample of 60 women with
irritable bowel syndrome
and 26 women with inflammatory bowel disease in an urban gastroenterology clinic using the National Institute of Mental Health Diagnostic Interview Schedule, the Briere Child Maltreatment Interview (emotional, physical and sexual abuse), and a structured interview to elicit a lifetime history of chronic pelvic pain that was distinct from the history of bowel distress. Chronic pelvic pain was reported in 21 (35.0%) of the
irritable bowel syndrome
patients vs. 4 (13.8%) of the inflammatory bowel disease group (p < 0.05). Compared to women with
irritable bowel syndrome
alone, those with both
irritable bowel syndrome
and chronic pelvic pain were significantly more likely to have a lifetime history of
dysthymic disorder
, current and lifetime panic disorder, somatization disorder, childhood sexual abuse and hysterectomy. Logistic regression showed that mean number of somatization symptoms was the best predictor of a history of both
irritable bowel syndrome
and chronic pelvic pain compared either to inflammatory bowel disease or
irritable bowel syndrome
alone. Many women with
irritable bowel syndrome
may have a history of chronic pelvic pain as well. The high rates of psychopathology associated with
irritable bowel syndrome
and chronic pelvic pain independently are even higher in women with both syndromes, and women who present with either
irritable bowel syndrome
or chronic pelvic pain should probably be evaluated for both disorders.
...
PMID:Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. 886 Aug 85
Irritable bowel syndrome
(
IBS
) has been reported in 10% to 22% of adults. The authors compared patients seeking treatment for
dysthymia
(N = 59) in an outpatient setting to an age- and sex-matched comparison group of patients (N = 54) seeking treatment in a general physician's office for other medical illnesses. The comparison group did not have any Axis I disorders.
IBS
was diagnosed by using the criteria established by Drossman and colleagues. Of the patients screened, 59.32% of the patients with
dysthymia
met criteria for
IBS
in contrast to 1.85% of the comparison group (P < 0.000005).
IBS
is extremely prevalent in patients seeking treatment for
dysthymia
and is often undiagnosed and untreated.
...
PMID:Irritable bowel syndrome and dysthymia. Is there a relationship? 899 18
Recent epidemiological surveys in general populations of different countries of the world found lifetime prevalence rates of major depressions between 3.3% and 17%. For
dysthymia
(depressed mood over a period of at least two years with at least two concomitant depressive symptoms) the prevalence rate was found to be between 2% and 7%. The prevalence rates of major depressions and
dysthymia
are usually higher for females than for males. Bipolar disorders can be observed in about 1% of a general population over lifetime, and they seem to be somewhat more common among males than females. Divorced and separated persons have a higher risk of suffering from major depressions than married persons. Major depressions are thought to be more common among members of the lowest social class than among people belonging to the upper classes. Major depressions usually start between the age of 25 and 30 years, and the age of onset of bipolar disorders is between the age of 18 and 30 years. For western industrial nations a secular trend towards an increase in the prevalence of major depressions may be presumed. However, such a secular trend has not yet been confirmed, owing to biases associated with methodological problems. A notable comorbidity of major depressions can be observed with all anxiety disorders, obsessive-compulsive disorders, eating disorders, post-traumatic stress disorder, disorders of impulse control, abuse and dependence of alcohol and of other legal and illegal drugs, pathological gambling, migraine, fibromyalgia and
irritable bowel syndrome
. This observation has led to the concept of an "affective spectrum". This phenomenon has to be kept in mind during the diagnostic process and treatment.
...
PMID:[Epidemiology and comorbidity of depressive disorders]. 1073 97
Depression is an aversion to activity disorder which could lead to somatic dysfunctions such as insomnia, excessive sleeping, body aches, listlessness, and
irritable bowel syndrome
. The World Health Organization has projected the depression to be the second leading cause of disability worldwide by 2020. The physical and mental ill effects of somatic depression can be addressed using the osteopathic manipulative treatment. Therefore, the purpose of the present case report is to explore the effect of myofascial release (MFR) technique and myofascial unwinding (MFU) in the somatic depression. We reported a case of a 39-year-old female diagnosed as
dysthymia
with moderate depression with somatic symptoms. She was treated with MFR and MFU for 4 weeks. Depression was scored using Hamilton Depression Rating Scale (HDRS), and quality of life was measured using the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF). Both were administered preintervention and 6 weeks postintervention. The application of MFR and MFU resulted in the improved scores on both HDRS and Q-LES-Q-SF. The present case positive results have proven the effectiveness of MFR and MFU as an important adjunctive treatment strategy.
...
PMID:Efficacy of Myofascial Unwinding and Myofascial Release Technique in a Patient with Somatic Symptoms - A Case Report. 2851 61